Protective effects of carvedilol in the myocardium (Q41669354)

6 October 2017

1 reference

title

Protective effects of carvedilol in the myocardium (English)

1 reference

6 October 2017

1 reference

G Z Feuerstein

1

1 reference

6 October 2017

A Bril

series ordinal

2

1 reference

6 October 2017

R R Ruffolo

series ordinal

3

1 reference

6 October 2017

language of work or name

English

0 references

publication date

1 December 1997

1 reference

American Journal of Cardiology

6 October 2017

published in

1 reference

6 October 2017

volume

80

1 reference

6 October 2017

issue

11A

1 reference

6 October 2017

page(s)

41L-45L

1 reference

Carvedilol, a novel vasodilating beta-blocker with the potential for cardiovascular organ protection

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

A hydroxylated analog of the beta-adrenoceptor antagonist, carvedilol, affords exceptional antioxidant protection to postischemic rat hearts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Effects of the free radical generating system FeCl3/ADP on reperfusion arrhythmias of rat hearts and electrical activity of canine Purkinje fibres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Reperfusion injury induces apoptosis in rabbit cardiomyocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Myocardial protection with carvedilol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol (Kredex&reg;) Reduces Infarct Size in a Canine Model of Acute Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Normal and abnormal consequences of apoptosis in the human heart. From postnatal morphogenesis to paroxysmal arrhythmias

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol prevents low-density lipoprotein (LDL)-enhanced monocyte adhesion to endothelial cells by inhibition of LDL oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol, a new vasodilating beta adrenoceptor blocker antihypertensive drug, protects endothelial cells from damage initiated by xanthine-xanthine oxidase and neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol, a new antihypertensive agent, prevents lipid peroxidation and oxidative injury to endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Carvedilol-liposome interaction: evidence for strong association with the hydrophobic region of the lipid bilayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Hypothesis: apoptosis may be a mechanism for the transition to heart failure with chronic pressure overload

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

Apoptosis in pressure overload-induced heart hypertrophy in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900847-3

10.1016/S0002-9149(97)00847-3

7 January 2021

Identifiers

DOI

1 reference

6 October 2017

1 reference